Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Schafmayer

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
BMC Cancer|May 11, 2019
Prognostic relevance of topoisomerase II α and minichromosome maintenance protein 6 expression in colorectal cancerA Hendricks, F Gieseler, S Nazzal, et al.
Oncogene|September 8, 2009
Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)A Arlt, I Bauer, C Schafmayer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2011
TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancerF A Castro, A Försti, S Buch, et al.
Endocrine-Related Cancer|February 15, 2011
Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer riskJ Sainz, A Rudolph, R Hein, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
A mechanistic, model-based approach to safety assessment in clinical developmentJ Lippert, M Brosch, O von Kampen, et al.
British Journal of Cancer|November 19, 2009
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancerI P M Tomlinson, M Dunlop, H Campbell, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
BMC Cancer|May 11, 2019
Prognostic relevance of topoisomerase II α and minichromosome maintenance protein 6 expression in colorectal cancerA Hendricks, F Gieseler, S Nazzal, et al.
Oncogene|September 8, 2009
Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)A Arlt, I Bauer, C Schafmayer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2011
TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancerF A Castro, A Försti, S Buch, et al.
Endocrine-Related Cancer|February 15, 2011
Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer riskJ Sainz, A Rudolph, R Hein, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
A mechanistic, model-based approach to safety assessment in clinical developmentJ Lippert, M Brosch, O von Kampen, et al.
British Journal of Cancer|November 19, 2009
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancerI P M Tomlinson, M Dunlop, H Campbell, et al.
Pageof 3